Morepen launches first US prescription generic
In short
Morepen has launched its first US prescription generic. The company also said it is looking at more filings.
The launch moves Morepen beyond API supplies into finished medicines and distribution in the US market.
What the reporting says
Morepen has launched its first US prescription generic, according to Business Standard, and said it is looking at further filings. The launch expands the company beyond API supplies into finished-dosage medicines and distribution. The move gives Morepen a wider presence in the US market, with the next step depending on additional regulatory filings.
Why it matters
Morepen’s launch of its first US prescription generic marks a move beyond API supplies into finished-dosage medicines and distribution, according to the Business Standard summary. The company also plans further filings, suggesting more products could follow. The development is relevant to Morepen’s US business expansion and product mix.